Literature DB >> 23796327

Radical lymphadenectomy in esophageal cancer: from the past to the present.

P Hiranyatheb1, H Osugi.   

Abstract

Lymphadenectomy as an essential part of the surgical treatment has been one of the most controversial aspects in the management of esophageal cancers. The purpose of this article was to review the evolution, the current role, and the optimal extent of lymphadenectomy for the treatment of esophageal cancers. Studies discussing the outcome of esophagectomy with lymph nodes dissection and comparing among different extent of lymphadenectomy were used in the analysis. Several studies including recently published articles reveal that additional radical lymphadenectomy may be beneficial in some patients with non-extreme esophageal cancer undergoing esophagectomy, whereas two-field lymph node dissection is suitable for distal esophageal cancers regardless of the histology of the tumor. Minimally invasive surgery and neoadjuvant therapy combined with radical surgery seem to show more benefit in selected cases, but further studies should be required to clearly demonstrate their efficacy and safety. The expertise and experience of the surgeons should also be taken into account in determining the success of these radical procedures.
© 2013 Wiley Periodicals, Inc. and the International Society for Diseases of the Esophagus.

Entities:  

Keywords:  en bloc esophagectomy; esophageal cancer; radical lymphadenectomy

Mesh:

Year:  2013        PMID: 23796327     DOI: 10.1111/dote.12091

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  10 in total

Review 1.  Guidelines for Perioperative Care in Esophagectomy: Enhanced Recovery After Surgery (ERAS®) Society Recommendations.

Authors:  Donald E Low; William Allum; Giovanni De Manzoni; Lorenzo Ferri; Arul Immanuel; MadhanKumar Kuppusamy; Simon Law; Mats Lindblad; Nick Maynard; Joseph Neal; C S Pramesh; Mike Scott; B Mark Smithers; Valérie Addor; Olle Ljungqvist
Journal:  World J Surg       Date:  2019-02       Impact factor: 3.352

Review 2.  Current status of predictive biomarkers for neoadjuvant therapy in esophageal cancer.

Authors:  Norihisa Uemura; Tadashi Kondo
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

3.  The role of 18F-FDG PET/CT in predicting the pathological response to neoadjuvant PD-1 blockade in combination with chemotherapy for resectable esophageal squamous cell carcinoma.

Authors:  Xiaoyan Wang; Weixiong Yang; Qian Zhou; Hui Luo; Wenfang Chen; Sai-Ching Jim Yeung; Shuishen Zhang; Yi Gan; Bo Zeng; Zhenguo Liu; Shiting Feng; Xiangsong Zhang; Chao Cheng
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-06-23       Impact factor: 10.057

4.  Clinical evaluation of right recurrent laryngeal nerve nodes in thoracic esophageal squamous cell carcinoma.

Authors:  Zhen-Xuan Li; Xiao-Dong Li; Xian-Ben Liu; Wen-Qun Xing; Hai-Bo Sun; Zong-Fei Wang; Rui-Xiang Zhang; Yin Li
Journal:  J Thorac Dis       Date:  2020-07       Impact factor: 2.895

5.  Prediction of postoperative inflammatory complications after esophageal cancer surgery based on early changes in the C-reactive protein level in patients who received perioperative steroid therapy and enhanced recovery after surgery care: a retrospective analysis.

Authors:  Kazuki Kano; Toru Aoyama; Tetsushi Nakajima; Yukio Maezawa; Tsutomu Hayashi; Takanobu Yamada; Tsutomu Sato; Takashi Oshima; Yasushi Rino; Munetaka Masuda; Haruhiko Cho; Takaki Yoshikawa; Takashi Ogata
Journal:  BMC Cancer       Date:  2017-12-04       Impact factor: 4.430

6.  Surgical anatomy of the supracarinal esophagus based on a minimally invasive approach: vascular and nervous anatomy and technical steps to resection and lymphadenectomy.

Authors:  Miguel A Cuesta; Nicole van der Wielen; Teus J Weijs; Ronald L A W Bleys; Suzanne S Gisbertz; Peter van Duijvendijk; Richard van Hillegersberg; Jelle P Ruurda; Mark I van Berge Henegouwen; Jennifer Straatman; Harushi Osugi; Donald L van der Peet
Journal:  Surg Endosc       Date:  2016-08-23       Impact factor: 4.584

7.  Diagnostic value of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for preoperative lymph node metastasis of esophageal cancer: A meta-analysis.

Authors:  Jingfeng Hu; Dengyan Zhu; Yang Yang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

8.  Clinical significance and outcomes of bilateral and unilateral recurrent laryngeal nerve lymph node dissection in esophageal squamous cell carcinoma: A large-scale retrospective cohort study.

Authors:  Shuishen Zhang; Qianwen Liu; Bin Li; Minghan Jia; Xiaoli Cai; Weixiong Yang; Shufen Liao; Zhongkai Wu; Chao Cheng; Jianhua Fu
Journal:  Cancer Med       Date:  2022-02-17       Impact factor: 4.452

9.  Development and validation of a nomogram for prediction of cervical lymph node metastasis in middle and lower thoracic esophageal squamous cell carcinoma.

Authors:  Zhaoyang Yan; Xinjian Xu; Juntao Lu; Yang You; Jinsheng Xu; Tongxin Xu
Journal:  BMC Gastroenterol       Date:  2022-04-03       Impact factor: 3.067

10.  Potential impact of (18)FDG-PET/CT on surgical approach for operable squamous cell cancer of middle-to-lower esophagus.

Authors:  Sujing Liu; Hui Zhu; Wanghu Li; Baijiang Zhang; Li Ma; Zhijun Guo; Yong Huang; Pingping Song; Jinming Yu; Hongbo Guo
Journal:  Onco Targets Ther       Date:  2016-02-22       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.